At Sandoz International/Novartis, some of his roles in the past eight years included Regional Head of Sales and Marketing as well as working in the Portfolio, Franchise and Key Account Management for Asia Pacific and as Interim Director in Australia. At Mepha Ltd. (Ratiopharm/TEVA), he was Regional Director for the Middle East and Country Director for Saudi-Arabia. Before that, he held positions at Murex Diagnostics (Abbott), focusing on Eastern Europe, at BASF Pharma Knoll International (Abbott), focusing on North America and Canada, as well as at Madaus AG (Mylan).
As Director of Global Sales, Marc Westermann directly reports to the Chairman of the Board, Dr. Marcus Wörwag.
Marcus Wörwag: "We concluded the year 2017 with a record turnover of 201 million euros. Our objective is a clearly defined growth for our pharmacy-exclusive biofactor preparations. To achieve that, we need a strong distribution organization: on the one hand, in our pre-existing markets in Russia, Eastern Europe and Central Asia. On the other hand, Marc Westermann will, together with local distribution partners, develop specifically targeted new markets in Asia, for instance in Thailand, and in Latin America."